Morris Kandinov LLP is representing Camac Fund, LP in an action against the board of directors of Forte Biosciences, Inc. and other defendants who attempted to fix the vote in advance of the company’s annual meeting.

U.S. District Court denies defendants’ motion to dismiss in dispute over $32.5 million termination fee payment.

The Delaware Chancery Court rejected an interlocutory appeal of the Court’s prior ruling denying defendants’ motion to dismiss, permitting discovery to proceed in the case.

The amended complaint in the Infinity Q case includes further details regarding the flawed and deficient oversight of the Fund’s valuation of securities, which resulted in manipulation and inflation of the fund’s reported assets by hundreds of millions of dollars.

Morris Kandinov LLP has filed a case on behalf of Lightning eMotors, Inc. (previously known as GigCapital 3, Inc.), which entered the public markets through a SPAC transaction based on misrepresentations regarding its business prospects.

Morris Kandinov LLP represents a group of investors who oppose the inadequate proposed Infinity Q settlement in a New York class action.

Morris Kandinov LLP represents investors in an action in New York seeking equitable distribution of a SPAC break-up fee.

Morris Kandinov LLP represents a New York pension fund in connection with a company’s breach of interim operating covenants during a pending merger that cost stockholders $400 million.

Morris Kandinov LLP has filed a class action complaint on behalf of investors in Concord Acquisition Corp. seeking to prevent the sponsor from appropriating a $20 million termination fee consisting of stock in the SPAC’s former target, Circle.

Morris Kandinov LLP has filed an action alleging that investors in Decarbonization Plus Acquisition Corporation were misled by its board of directors prior to the acquisition of Hyzon Motors Inc. (HYZN) in July 2021.